In vitro cytocompatibility and cellular interactions of lauric acid and dextran-coated magnetite nanoparticles were evaluated with two different cell lines (mouse fibroblast and human cervical carcinoma). Lauric acid-coated magnetite nanoparticles were less cytocompatible than dextran-coated magnetite nanoparticles and cellular uptake of lauric acid-coated magnetic nanoparticles was more than that of dextran-coated magnetite nanoparticles. Lesser cytocompatibility and higher uptake of lauric acid-coated magnetite nanoparticles as compared to dextran-coated magnetic nanoparticles may be due to different cellular interactions by coating material. Thus, coating plays an important role in modulation of biocompatibility and cellular interaction of magnetic nanoparticles.
With the advent of nanotechnology, research in the area of biomedical applications of magnetic nanoparticles has received an impetus due to its potential applications in cellular labeling, magnetic resonance imaging, drug delivery and hyperthermia treatment of cancer [1, 2] . For most of the in vivo applications, magnetic nanoparticles are generally used in the form of magnetic fluids. Biocompatibility of aqueous magnetic fluids is determined by both core material and the coatings [3] . Most widely used biocompatible magnetic fluid is magnetite (Fe 3 O 4 ) based [4] . Several surfactant-and polymer-based coating materials like citrate, polyaspertic acid, dextran have been tested for biocompatibility [4] [5] [6] [7] [8] . Dextran coating has been used mostly because of its biocompatibility [4, 9] . However, use of dextran coating has been restricted due to loss of dextran shell by enzymatic degradation in vivo [9] . In this study, we evaluated the biocompatibility of lauric acid (dodecanoic acid) as a coating material for the stabilization of magnetic particles in aqueous-based magnetic fluids (LMN) comparatively with dextran (DMN). Lauric acid is a fatty acid having 12 (C12) carbon chains which gives stable and dilution insensitive water-based magnetic fluid [10] . Further, C12 is a natural medium chain fatty acid and is already approved for use in pharmaceuticals and food industry [11] .
Different coatings can modify the cellular interactions of magnetic nanoparticles in terms of their adhesion, internalization and intracellular fate following internalization [12] .
Magnetite (Fe 3 O 4 ) nanoparticles were prepared by a standard co-precipitation method in N 2 atmosphere [10] . For this, FeCl 2 and FeCl 3 salts (molar ratio 1:2) (SigmaAldrich, USA) were dissolved in deionized N 2 -purged water. In case of LMN magnetic fluid the metal ions solution (0.2 M) was quickly added into the base solution (NH 4 OH) with vigorous stirring (3000 rpm). The pH of the resultant reaction mixture was 10-10.5. The pH was monitored by a pH meter (Toshcon, India). The slurry was aged between 90 and 95 1C for 15-20 min. The precipitate was repeatedly washed with 10% NH 4 OH solution. The lauric acid (30-40 wt% of ferrite) (SigmaAldrich, USA) and water are added to the washed nanoparticles. This mixture was kept on a hot plate and heated ($100 1C) for 10 min with stirring to form ferrofluid. For dextran-coated magnetic fluid, the metal ions solution was added to dextran (Sigma-Aldrich, USA) solution in deionized N 2 -purged water and stirred vigorously in N 2 atmosphere. Then 25% ammonia solution was added to the polymer metal ions mixture. The reaction mixture was further heated at 60-70 1C for 30 min. The DMN and LMN were subjected to dialysis for removal of excess surfactant/polymers and other impurities (NH 4 + ions). The resultant magnetic fluids were centrifuged at 3500g for 10-15 min followed by filtration using the Whatman 2 (qualitative) to get purified magnetic fluids. The pH of resultant LMN (27 mg/ml Fe 3 O 4 ) and DMN (11 mg/ml Fe 3 O 4 ) ferrofluids was 7.2-7.4. Determination of magnetic phase purity of magnetic fluids was done by X-ray diffraction (XRD) studies using Philips powder diffractometer PW1710 with CuK a radiation. Samples were scanned in continuous mode from 201-801 with a scanning rate of 0.021/15. Few drops of ferrofluid sample was put with clean glass slide and dried at 90 1C to form a thin layer of nanoparticles. This glass slides were used for X-ray study. The crystallite size was determined from the X-ray line broadening using Scherrer's formula. The size and morphology of the coated particles in the ferrofluid were observed using a transmission electron microscope (TEM) (CM 200, Philips). For TEM observation, magnetic fluids (10-30 mg particles/ml) were diluted 10 times and the samples were deposited dropwise onto a copper grid coated with carbon film and dried. The low-temperature as well as room-temperature magnetization measurements of ferrofluid and powder were done with a vibrating sample magnetometer (VSM, Lake Shore, Model-7410).
Comparative in vitro biocompatibility studies of LMN and DMN were done with L929 (mouse fibroblast) cell lines procured from National Centre for Cell Science (NCCS), Pune, India. The cells were grown in Dulbecco's modified eagle medium (DMEM, Sigma Aldrich, USA) supplemented with 10% fetal bovine serum (FBS Sigma Aldrich, USA) and 1% antibiotic antimycotic solutions (Himedia, India) and incubated at 37 1C temperature under 5% CO 2 and saturated humid environment. Nearly confluent cells in 25 cm 2 tissue culture flask (Nunc, USA) were harvested by trypsin-EDTA solution and centrifuged at 1000g for 10 min. The cell pellet was resuspended in fresh media. 1 Â 10 4 cells were added to each well of a 96 well tissue culture plate (Nunc, USA) and incubated in a CO 2 incubator (Jouan IG150, France). After 24 h, the samples were added in five different ferrite concentrations ranging from 0.05 to 0.6 mg/ml of culture medium. After 24 h, SRB (sulphorhodamine B, Sigma-Aldrich Chemie, USA) assay was conducted similar to the procedure by Skehan et al. [13] with slight modifications. In brief, cells were fixed by adding 50 ml of ice-cold 50% trichloroacetic acid (TCA, Loba Chemie, India) slowly to the medium and incubated at 4 1C for 1 h. Then, the plates were washed five times with deionized water and dried in air. 100 ml of 0.4% sulforhodamine B (Sigma, USA) dissolved in 1% acetic acid was added to the fixed cells and kept at room temperature for 20 min after which they were washed with 1% acetic acid to remove unbound dye. The plates were dried and 100 ml of 10 mM Tris base (Sigma, USA) was added to each well and kept for 20 min to solubilize the dye. Thereafter, the plates were placed on a shaker to allow mixing and the absorbance (optical density) of each well was read in a plate reader (Thermo Electron Corporation, USA) at 560 nm. Cell viability was measured as viability (%) ¼ (absorbance of sample/absorbance of control) Â 100. After fixing the cells with 50% trichloroacetic acid, photographs were taken under bright field in a phase contrast microscope for evaluation of cell morphology and growth.
Qualitative and quantitative internalization studies of LMN and DMN were done with HeLa (human cervical carcinoma) and L929 (mouse fibroblast) cell lines. Qualitative evaluation of magnetic nanoparticles internalization was done by prussian blue staining. Iron deposition within the cells was detected by characteristic blue color of prussian blue. For this study, cells were first grown on cover slips for 24 h after which they were exposed to LMN and DMN at different concentrations (0.2 and 0.4 mg/ml of cell culture suspension) for 24 and 48 h. The cover slips were then immersed in a mixture containing equal volume of 20% aqueous solution of HCl and 10% aqueous solution of potassium ferrocyanide [K 4 Fe(CN) 6 , 3H 2 O] for 20 min and counterstaining was done by nuclear fast red for 5 min. Photographs were taken in bright field mode using Olympus BX 51 microscope.
The quantitative determination of intracellular iron uptake was done by ICP-AES (inductively coupled plasma atomic emission spectroscopy, Labtam, Australia). For this study, the cells exposed to magnetic nanoparticles (as before) were washed 3-4 times thoroughly by phosphate buffer saline solution (pH-7.4) and trypsinized. Cells were then centrifuged at 1000g for 10 min to form a pellet of cells. The cells pellet was dissolved in concentrated HCl (37%) to digest the cells and release ferric iron ions from ferrite particles. Concentration of Fe +3 ions in the solution was measured by ICP-AES.
For visualization of internalized particles by TEM, HeLa cells treated with LMN at 0.2 mg/ml ferrite concentration was processed as monolayer. The procedure is described elsewhere in the literature [9] . Photographs were taken in a Philips, TECHNA G 2 120 TEM. Statistical analysis of the data was done by analysis of variance (ANOVA) using Microsoft Excel 2000 software. Data were represented as mean7standard deviation (SD) for three replicates (n ¼ 3).
The XRD patterns (data not shown) of ferrophase in two magnetic fluids (LMN and DMN) showed formation of pure single-phase cubic Fe 3 O 4 . From the TEM micrographs (figures not shown) of LMN and DMN, it was observed that the particles were nearly spherical in shape and were well dispersed. The mean Fe 3 O 4 particle sizes in DMN and LMN ferrofluid were 7 and 10 nm, respectively. The mean particle sizes were determined by considering about 250 particles of the TEM images. This was in good agreement with the crystallite size measured from the X-ray line (3 1 1) broadening using Scherrer's formula. The room temperature (27 1C) magnetization curves of Fe 3 O 4 particles of the magnetic fluids did not show any remanence or coercivity forces, which indicated that the magnetic particles were superparamagnetic in nature. Fig. 1 shows the comparative cytocompatibility of LMN and DMN on L929 cells at 24 h of incubation. It is evident from these data that upto 0.2 mg/ml ferrite concentration, LMN and DMN have comparable cytocompatibility. However, at higher concentrations (at 0.4 and 0.6 mg/ml) LMN showed decreased cell viability (o90%), whereas DMN showed similar cell viability percentage as control. This indicates that DMN is completely cytocompatible at these concentrations. But, LMN inhibits cell growth at higher concentrations i.e. at 0.4 and 0.6 mg/ml. It is also to be noted that DMN was cytocompatible even at the ferrite concentration of 2 mg/ml, which was the highest concentration tested in L929 cell lines (data not shown). For HeLa cells, LMN and DMN showed similar trends in cytocompatibilty as L929 cells except that LMN showed more loss of cell viability (410%) at higher concentrations (X0.2 mg/ml) as compared to L929 cells (data not shown).
Morphology and growth of L929 cells following exposure of different concentrations of LMN and DMN are represented in Fig. 2 . The figure clearly shows that at 0.1 mg/ml concentration, the growth and morphology of L929 cells for both LMN and DMN were not altered as compared to control. However, at 0.6 mg/ml concentration of LMN, the cell growth was decreased and the cells appeared more granular and the typical shape of the fibroblast cell was lost. This indicates that higher concentration (i.e. 0.6 mg/ml) of LMN was detrimental for normal cell growth. However, DMN was cytocompatible at 0.6 mg/ml concentration as evident by unaltered growth and morphology of L929 cells. As the nature of ferrite was the same (i.e. magnetite) for both the LMN and DMN, coating materials could play an important role in modulating cytocompatibility of magnetite. On the other hand, lauric acid was found to be nontoxic to L929 cells upto 800 mM (0.16 mg/ml), which was more than the lauric acid content of highest LMN concentration (lauric acid content-0.06 mg/ml) tested for cytocompatibility i.e. 0.6 mg/ml (data not shown). However, LMN did not show cytocompatibility at 0.6 mg/ml concentration, which could be due to different cellular interactions of LMN unlike DMN. Fig. 3 shows the amount of LMN and DMN uptake in terms of total iron by HeLa and L929 cells following different periods of incubation. For HeLa cells, LMN uptake was independent of extracellular concentrations as well as periods of incubation, whereas DMN uptake was increased with extra cellular concentrations and periods of incubation ( Fig. 3(a) ). However, the amount of LMN uptake was more than DMN in HeLa cells. For L929 cells, both the LMN and DMN uptake were independent of extracellular concentration and periods of incubation (Fig. 3(b) ). No significant difference (p40.05; ANOVA) in the uptake of LMN was found between the cell lines after 48 h of incubation. However, DMN was found to be internalized relatively more in HeLa cells than L929 cells at 48 h of incubation (nonsignificant, p40.05; ANOVA). Moreover, DMN did not show any saturation in internalization unlike LMN within the dose ranges evaluated. Fig. 4 shows the photomicrographs of prussian blue stained HeLa and L929 cells for control and LMN (at 0.2 mg/ml for 24 h) treated groups. From these photographs it is observed that both the HeLa and L929 cells took up the blue color, which indicates the presence of the magnetic particles within the cells. Control cells did not show any blue color indicating absence of particle within the cells. DMN also showed similar results (data not shown). From ICP-AES and prussian blue studies, it is clear that the particles are associated with the cells (either on the surface or internalized within the cells). Their specific location in the cells can be visualized by TEM, however. Fig. 5 shows transmission electron micrographs of HeLa cells, which were incubated with LMN at 0.2 mg/ml concentration for 24 h. From these TEM photographs it is observed that particles are present both on cell surface ( Fig. 5(a) ) and in the intracellular space i.e. cytoplasm ( Fig. 5(b) ). After magnification of cytoplasm particles, it was seen that particles are located within a vesicle-like structure (inset of Fig. 5(b) ), which was suggestive of endocytosis of the particles.
From this internalization study, it is clear that uptake of magnetic particle is mainly based on nature of the surface coatings. Similar findings are also reported in literature for dextran coated and anionic superparamagnetic nanoparticles [14] . Nonsaturable internalization of DMN found in this study corroborates with the earlier reports [9, 15] . The mechanism of uptake of DMN occurs via fluid phase endocytosis, not via receptor-mediated endocytosis as evident by the nonsaturation of DMN uptake and absence of binding sites for dextran on the plasma membrane of the cells as reported in literature [14, 16] . However, for LMN such tendency of nonsaturation of particle uptake is not observed. Rather, uptake is independent of incubation period, which suggests a different mechanism of uptake for lauric acid-coated particles. In case of anionic nanoparticles, uptake occurs via two processes like initial adsorption of anionic particles on the scarce cationic sites of the cell membrane due to electrostatic interactions followed by formation of particle aggregates on the cell membrane due to repulsive interactions with the large negatively charged domains of the cell surface. Hence, higher uptake of anionic nanoparticles compared to dextran-coated nanoparticles is favored by their surface negative charges, mainly due to carboxylate groups and absence of any steric coating as conferred by dextran. In LMN, higher uptake of LMN irrespective of cell types and durations as compared to DMN can be explained by the electrostatic interaction of LMN (anionic in nature as evident by its zetapotetial) unlike steric interaction for DMN. Granular appearance of the cells at higher concentration could be attributed to the presence of particles in cells [17] and altered shape of the cells may be due to endocytosis of particles internalization of particles and reorganization of cytoskeleton components like actin and tubulin [18, 19] . However, further study is required to elucidate the mechanism of uptake and toxicity of lauric acid-coated particles at higher concentrations. From this study, it can be concluded that lauric acidcoated magnetite nanoparticles are less cytocompatible than dextran-coated magnetic nanopartilcles and cellular uptake of lauric acid-coated magnetic nanoparticles is more than dextran-coated magnetic nanoparticles. Also, coating plays an important role in modulation of biocompatibility and cellular interaction of magnetic nanoparticles. 
